journal
https://read.qxmd.com/read/38967657/nuclear-imaging-techniques-for-cardiac-amyloidosis
#1
JOURNAL ARTICLE
Jean Michel Saad, Mouaz H Al-Mallah
PURPOSE OF REVIEW: Cardiac amyloidosis is a condition marked by the misfolding of precursor proteins into insoluble amyloid fibrils, leading to restrictive cardiomyopathy and heart failure symptoms. This review discusses advancements in nuclear imaging techniques that enhance the diagnosis and guide the management of cardiac amyloidosis, addressing the critical need for early and accurate detection in clinical practice. RECENT FINDINGS: Recent studies and guidelines emphasizes the pivotal role of nuclear imaging techniques in diagnosing cardiac amyloidosis...
July 8, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38963426/cardiac-magnetic-resonance-findings-in-cardiac-amyloidosis
#2
JOURNAL ARTICLE
Aneesh Dhore-Patil, Vivek Modi, Gabr El-Moatasem, Akila Bersali, Amr Darwish, Dipan Shah
PURPOSE OF REVIEW: The purpose of this review is to highlight the increasing importance of cardiac magnetic resonance (CMR) imaging in diagnosing and managing cardiac amyloidosis, especially given the recent advancements in treatment options. RECENT FINDINGS: This review emphasizes the crucial role of late gadolinium enhancement (LGE) with phase-sensitive inversion recovery (PSIR) techniques in both diagnosing and predicting patient outcomes in cardiac amyloidosis...
July 4, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38935044/improving-diversity-in-cardiac-surgery-clinical-trials-with-roma-women-as-an-exemplar
#3
JOURNAL ARTICLE
Ruth Masterson Creber, Sarah Eslami, Mario Gaudino
PURPOSE OF REVIEW: To describe methods to improve representation of women in cardiac surgery clinical trials. RECENT FINDINGS: Cardiovascular disease risk among women is high. Historically, women have been excluded from cardiac surgery trials, in part due to restrictive inclusion criteria. Surgical outcomes, specifically after coronary artery bypass grafting, are consistently worse among female patients, and these outcomes have not improved over the last decade...
June 26, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38904280/left-main-revascularization-guidelines-navigating-the-data
#4
JOURNAL ARTICLE
Aurelien Vallée, Kenza Rahmouni, Menaka Ponnambalam, Hugo Issa, Marc Ruel
PURPOSE OF REVIEW: This article explores recent developments in left main revascularization, with a focus on appraising the latest American and European guidelines. RECENT FINDINGS: Recent pooled data analysis from four major randomized controlled trials (RCTs) for left main coronary artery stenosis indicate an advantage for CABG over PCI in regard to freedom from major adverse cardiovascular events, despite no significant difference in mortality observed at 5 years...
June 21, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38899782/subclinical-valve-leaflet-thrombosis-following-bioprosthetic-aortic-valve-replacement
#5
JOURNAL ARTICLE
Carlos Giuliani, Antonela Zanuttini, Erwan Salaun, Nancy Côté, Marie Annick Clavel, Philippe Pibarot
PURPOSE OF REVIEW: Subclinical leaflet thrombosis (SLT) is often an incidental finding characterized by a thin layer of thrombus involving one, two or three leaflets, with typical appearance on multi-detector computed tomography (MDCT) of hypo-attenuating defect at the aortic side of the leaflet, also called hypo-attenuating leaflet thickening (HALT). SLT may occur following both transcatheter aortic replacement (TAVR) or biological surgical aortic valve replacement (SAVR). The aim of this review is to present an overview of the current state of knowledge on the incidence, diagnosis, clinical impact, and management of SLT following TAVR or SAVR...
June 20, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38847610/vascular-regenerative-cell-content-in-south-asians-the-key-learnings
#6
JOURNAL ARTICLE
Aishwarya Krishnaraj, Fallon Dennis, Hwee Teoh, Subodh Verma, David A Hess
PURPOSE OF REVIEW: We aim to provide a comprehensive examination of the literature linking elevated rates of cardiovascular disease (CVD) in individuals of South Asian ethnicity with the severity of circulating vascular regenerative cell exhaustion. RECENT FINDINGS: Recent findings have demonstrated reduced bioavailability of pro-vascular progenitor cell subsets in individuals with T2D and obesity. Depletion of vascular regenerative cells in the bone marrow - coupled with decreased mobilization into circulation - can negatively impact the capacity for vascular repair and exacerbate CVD risk...
June 10, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38743663/hypertrophic-cardiomyopathy-and-competitive-sports-let-em-play
#7
JOURNAL ARTICLE
Mats Steffi Jennifer Masilamani, Bryan Cannon
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM) is one of the most common cardiovascular genetic conditions. Although most patients with HCM typically do well clinically, there is a small but real incidence of sudden cardiac death. A diagnosis of HCM was previously a reason for complete exclusion in sports, particularly competitive sports.However, many of these recommendations are based on expert consensus, and much data has been published in the last decade furthering the scientific knowledge in this area, and allowing athletes who may have been previously excluded the potential to participate in strenuous activities and competitive sports...
May 13, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652263/treatment-of-transthyretin-cardiac-amyloidosis
#8
JOURNAL ARTICLE
Dimitrios Bampatsias, Abdirahman Wardhere, Mathew S Maurer
PURPOSE OF REVIEW: Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-CM, as the results of two phase 3 trials were published and several other trials are in their final stages. In this review, we summarize current and future therapies for ATTR-CM. RECENT FINDINGS: Recently, acoramidis, a TTR stabilizer has been proven to be effective in reducing mortality and morbidity compared to placebo in the ATTRibute-CM trial...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652248/genetic-aortopathies-a-case-based-approach-to-multidisciplinary-program-development
#9
JOURNAL ARTICLE
Christopher P Jordan, Akos Berthold, Jason Bonomo
PURPOSE OF REVIEW: The incorporation of genetic counseling and testing is essential to evaluation and management of thoracic aortic disease in patients under 60 years of age and those with family histories suspicious for heritable thoracic aortic disease and disorders associated with increased risk for acute type-A aortic dissection. RECENT FINDINGS: As many as 20% of individuals with thoracic aortic disease under the age of 60 years have autosomal dominant patterns of inheritance...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652290/recent-advances-in-multimodal-imaging-in-tetralogy-of-fallot-and-double-outlet-right-ventricle
#10
JOURNAL ARTICLE
Aakansha Ajay Vir Singh, Shi-Joon Yoo, Mike Seed, Christopher Z Lam, Israel Valverde
PURPOSE OF REVIEW: In the ever-evolving field of medical imaging, this review highlights significant advancements in preoperative and postoperative imaging for Tetralogy of Fallot (TOF) and double outlet right ventricle (DORV) over the past 18 months. RECENT FINDINGS: This review showcases innovations in echocardiography such as 3D speckle tracking echocardiography (3DSTE) for assessing right ventricle-pulmonary artery coupling (RVPAC) and Doppler velocity reconstruction (DoVeR) for intracardiac flow fields evaluation...
April 17, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38832818/from-remnant-cholesterol-to-lipoprotein-a-emerging-risk-factors-for-cardiovascular-diseases-beyond-low-density-lipoprotein
#11
EDITORIAL
Debabrata Mukherjee, Dimitri P Mikhailidis
No abstract text is available yet for this article.
July 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38661130/myocarditis-in-children-2024-new-themes-and-continued-questions
#12
REVIEW
Jason F Goldberg, Joseph A Spinner, Jonathan H Soslow
PURPOSE OF REVIEW: While pediatric myocarditis incidence has increased since the coronavirus disease 2019 (COVID-19) pandemic, there remain questions regarding diagnosis, risk stratification, and optimal therapy. This review highlights recent publications and continued unanswered questions related to myocarditis in children. RECENT FINDINGS: Emergence from the COVID-19 era has allowed more accurate description of the incidence and prognosis of myocarditis adjacent to COVID-19 infection and vaccine administration as well that of multi-system inflammatory disease in children (MIS-C)...
July 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38603529/prevention-and-treatment-of-hypertensive-left-ventricular-hypertrophy
#13
REVIEW
Manvita Tatavarthy, John Stathopoulos, Ahmet Afşin Oktay
PURPOSE OF REVIEW: Left ventricular (LV) hypertrophy (LVH) is a well recognized target organ adaptation to longstanding uncontrolled hypertension and other cardiovascular risk factors. It is also a strong and independent predictor of many cardiovascular disorders. RECENT FINDINGS: This focused review explores the current concepts in screening, diagnosis, prevention, and treatment of LVH in patients with hypertension. Currently, the primary screening and diagnostic tools for LVH are ECG and 2D echocardiography...
July 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38567949/integration-of-palliative-care-across-the-spectrum-of-heart-failure-care-and-therapies-considerations-contemporary-data-and-challenges
#14
REVIEW
Sarah Chuzi, Katharine Manning
PURPOSE OF REVIEW: Heart failure (HF) is characterized by significant symptoms, compromised quality of life, frequent hospital admissions, and high mortality, and is therefore well suited to palliative care (PC) intervention. This review elaborates the current PC needs of patients with HF across the spectrum of disease, including patients who undergo advanced HF surgical therapies, and reviews the current data and future directions for PC integration in HF care. RECENT FINDINGS: Patients with chronic HF, as well as those who are being evaluated for or who have undergone advanced HF surgical therapies such as left ventricular assist device or heart transplantation, have a number of PC needs, including decision-making, symptoms and quality of life, caregiver support, and end-of-life care...
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38567948/implementation-of-remote-monitoring-strategies-to-improve-chronic-heart-failure-management
#15
REVIEW
Vinh Q Chau, Teruhiko Imamura, Nikhil Narang
PURPOSE OF REVIEW: The goal of this review is to describe the current evidence available for remote monitoring devices available for patients with chronic heart failure, and also detail practical clinical recommendations for implementing these tools in daily clinical practice. RECENT FINDINGS: Several devices ranging from sophisticated multiparametric algorithms in defibrillators, implantable pulmonary artery pressure sensors, and wearable devices to measure thoracic impedance can be utilized as important adjunctive tools to reduce the risk of heart failure hospitalization in patients with chronic heart failure...
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38567947/editorial-gene-based-renaming-of-human-diseases
#16
JOURNAL ARTICLE
Ali J Marian
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38483006/genetic-causes-of-lymphatic-disorders-recent-updates-on-the-clinical-and-molecular-aspects-of-lymphatic-disease
#17
REVIEW
Catharine Bowman, Stanley G Rockson
PURPOSE OF REVIEW: The lymphatic system facilitates several key functions that limit significant morbidity and mortality. Despite the impact and burden of lymphatic disorders, there are many remaining disorders whose genetic substrate remains unknown. The purpose of this review is to provide an update on the genetic causes of lymphatic disorders, while reporting on newly proposed clinical classifications of lymphatic disease. RECENT FINDINGS: We reviewed several new mutations in genes that have been identified as potential causes of lymphatic disorders including: MDFIC, EPHB 4 , and ANGPT2...
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38375816/sleep-disordered-breathing-in-heart-failure
#18
REVIEW
Gregory R Jackson, Justin Durland, Frank Hoyland
PURPOSE OF REVIEW: This review addresses the evolving intersection of sleep-disordered breathing (SDB) and heart failure, a topic of increasing clinical significance due to the high prevalence of SDB in heart failure patients and its impact on morbidity and mortality. It reflects recent advancements in diagnostic methodologies and therapeutic strategies. It emphasizes the need for heightened awareness among healthcare providers about the complex relationship between SDB and various forms of heart failure...
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38362936/decongestion-instead-of-ultrafiltration
#19
REVIEW
Art Schuermans, Frederik H Verbrugge
PURPOSE OF REVIEW: To summarize the contemporary evidence on decongestion strategies in patients with acute heart failure (AHF). RECENT FINDINGS: While loop diuretic therapy has remained the backbone of decongestive treatment in AHF, multiple randomized clinical trials suggest that early combination with other diuretic classes or molecules with diuretic properties should be considered. Mineralocorticoid receptor antagonists and sodium-glucose co-transporter-2 inhibitors are disease-modifying drugs in heart failure that favourably influence prognosis early on, advocating their start as soon as possible in the absence of any compelling contraindications...
May 1, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38353280/intravenous-iron-in-patients-with-iron-deficiency-and-heart-failure-a-review-of-modern-evidence
#20
REVIEW
Stormi E Gale, Andrew Willeford, Katherine Sandquist, Kristin Watson
PURPOSE OF REVIEW: Iron deficiency is common in patients with heart failure, affecting up to half of ambulatory patients and an even greater percentage of patients admitted for acute decompensation. Iron deficiency in this population is also associated with poor outcomes, including worse quality of life in addition to increased hospitalizations for heart failure and mortality. Evidence suggests that patients with iron deficiency in heart failure may benefit from repletion with IV iron...
May 1, 2024: Current Opinion in Cardiology
journal
journal
29307
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.